Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
Abstract Parkinson's disease (PD) is the second most frequent neurodegenerative brain disease (NBD) after Alzheimer's disease (AD). Statins are the most common lipid‐lowering agents used in the management of dyslipidemia and the prevention of primary and secondary cardiovascular diseases (CVD) event...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wiley
2023-04-01
|
| Ráidu: | Pharmacology Research & Perspectives |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1002/prp2.1063 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|